Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (4384)	10/17/1998 1:41:00 AM
From: VBroady	Read Replies (4) \| Respond to of 5402

Synthetic Blood?? Yikes!! Wouldn't want to be "Ben." Who's gonna have the guts to be the first human trial?? New to this thread, and have read quite a few of the posts -- this stock/company is pretty exciting. You'd think a very large company would be involved in a project like this -- this company seems fairly small. Lotta upside -- FDA approval, too, for testing, etc? Gives new meaning to high risk/high reward. If this ever makes it to the "human level" and actually can "substitute" for a quantity/percentage of a person's blood --- WOW!! This is a longshot, but, hell - what rewards!! This stock would be worth a fortune!! Instant buy-out possibilities to the company/rights if the "mouse" lives, etc. Good luck -- I'll be watching this one -- not buying right now -- don't like to chase a stock -- 50% - nice move! vb